Newly announced rules that limit the use of COVID vaccines suggest that federal officials are opposed to open discussion and transparency.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
A study from Israel published today in BMJ shows that the effectiveness of a fourth dose of Pfizer-BioNTech's mRNA COVID vaccine waned faster than a third dose in adults ages 60 and older.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
A large study shows a 12.8% long COVID decline after the first dose and an 8.8% drop after the second.
Only 16% of people in low-income countries have received a single COVID vaccine dose.
More adults died of COVID-19 in Massachusetts in the first 8 weeks of the SARS-CoV-2 Omicron variant surge than in the entire 23-week Delta period, suggests a modeling study published today in JAMA.
The recommendation passed with 11 yes votes, 1 no vote, and 1 abstention.
Three quarters of US adult and pediatric patients with long COVID were never hospitalized for their infections, and 31% had no preexisting chronic conditions, concludes an observational Fair Health report released yesterday.
The New York City-based nonprofit analyzed its collection of private healthcare claims data from 78,252 long-COVID patients from Oct 1, 2021, to Jan 31, 2022.
